NVP-TAC544
NVP-TAC544 is a focal adhesion kinase (FAK) inhibitor. NVP-TAC544 inhibits angiogenesis. NVP-TAC544 can be used for the research of melanoma (primary or metastatic).
For research use only. We do not sell to patients.
- CAS No.: 761436-62-8
- Formula: C22H25BrN6O4S
- Molecular Weight:549.44
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
NVP-TAC544 (0.1-2.5 μM; 1 h) dose-dependently inhibits FAK pY397 phosphorylation and increases Pyk2 pY402 phosphorylation in bovine aortic endothelial cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:bovine aortic endothelial cells (BAECs)
-
Concentration:0.1 μM; 0.25 μM; 0.5 μM; 1 μM; 2.5 μM
-
Incubation Time:1 h
-
Result:Induced a dose-dependent decrease in FAK pY397 phosphorylation, with near-complete inhibition observed at concentrations ≥0.25 μM.
Induced a dose-dependent increase in Pyk2 pY402 phosphorylation, with peak activation (~2.5-fold increase versus DMSO control) observed at 0.25-1 μM.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6 (age-matched littermates; wild-type and inducible endothelial cell-specific FAK knockout (i-EC-FAK-KO) genotypes)[1]
-
Dosage:40 mg/kg
-
Administration:i.p.; daily
-
Result:Reduced bFGF-mediated angiogenesis by 80% in wild-type mice (P < 0.05).
Exerted no effect on bFGF-mediated angiogenesis in i-EC-FAK-KO mice.
Chemical Information
-
CAS No. 761436-62-8
-
Molecular Weight 549.44
-
Formula C22H25BrN6O4S
-
SMILES
O=S(NC)(C1=C(NC2=NC(NC3=CC=C(N4CCOCC4)C=C3OC)=NC=C2Br)C=CC=C1)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Human pluripotent stem cell endothelial-cell differentiation
Human pluripotent stem cell endothelial differentiation is based on stepwise developmental patterning: early activation of WNT/GSK3β inhibition promotes mesodermal or vascular progenitor entry, followed by endothelial specification using VEGF-related signaling, BMP4, FGF2, Notch modulation, or cAMP depending on the published protocol. Endothelial differentiation is read out by acquisition of CD31, CD34, VE-cadherin/CD144, KDR/VEGFR2, vWF, Tie2, NOS3, acetylated LDL uptake, tube/network formation, barrier function, and in vivo vessel-forming capacity where tested.
-
Vascular/Branching Fractal Analysis
Vascular/branching fractal analysis quantifies the geometric complexity of vessel trees or vascular networks from segmented 2D images, commonly by converting vessels into binary and/or skeletonized maps and estimating fractal dimension using box-counting or related approaches. Fractal dimension is interpreted as an image-derived readout of vascular branching complexity, space filling, or density, and has been applied to retinal photographs, fluorescein angiography, OCT angiography, capillary perfusion maps, and in vitro Matrigel angiogenesis networks. The assay readout is generated from vessel-positive pixels after image preprocessing, vessel segmentation, binarization, and optional skeletonization; reported outputs include fractal dimension, vessel density, branchpoint density, endpoint density, vessel length density, tortuosity, and generation-based branching metrics when VESGEN-style analysis is used. The biological interpretation is limited to quantitative vascular patterning and s
-
Endothelial Tube Formation Assay
Endothelial tube formation assay evaluates the ability of endothelial cells to attach, migrate, align, and organize into capillary-like networks when cultured on gelled basement membrane extract or Matrigel; the readout is the morphology and quantity of tube-like networks, which reflects an in vitro endothelial morphogenesis step related to angiogenesis. Basement membrane extract/Matrigel provides laminin-rich extracellular matrix cues that support endothelial differentiation into capillary-like structures, but it can contain biologically active growth factors, so growth-factor-reduced matrix is preferred when testing defined angiogenic stimulators or inhibitors.
-
Endothelial Cell Migration/Angiogenic Sprouting Assay
Endothelial cell migration and angiogenic sprouting assays are in vitro (and partially ex vivo-adapted) functional models that quantify the ability of endothelial cells to undergo coordinated migration, extracellular matrix invasion, and multicellular organization into capillary-like sprouts in response to pro-angiogenic stimuli such as VEGF, bFGF, or conditioned microenvironments. These assays are used to model early angiogenic events including tip-cell formation, directional migration, and lumen-like sprout extension, which collectively reflect angiogenic activation and vascular morphogenesis processes observed in vivo.
Purity & Documentation
References
[1]. Weis SM, et al. Compensatory role for Pyk2 during angiogenesis in adult mice lacking endothelial cell FAK. J Cell Biol. 2008;181(1):43-50. [Content Brief]
[2]. Chuang HH, et al. FAK in Cancer: From Mechanisms to Therapeutic Strategies. Int J Mol Sci. 2022;23(3):1726. Published 2022 Feb 2. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)